Attentional bias in tobacco use disorder using eye tracking: A systematic review Noreen Rahmani, Alma Rahimi, Kameron Iturralde, Laurie Zawertailo Attentional bias, defined as the disproportionate attentional allocation towards drug-related stimuli, is well-demonstrated in substance use disorders. However, studies investigating attentional bias in tobacco use disorder have revealed inconclusive findings. In recent years, eye-tracking technology has emerged as an innovative technique for exploring…

https://www.researchprotocols.org/2024/1/e60677

The effects of alcohol use on smoking cessation treatment with nicotine replacement therapy: An observational study Benjamin Wong, Scott Veldhuizen, Nadia Minian, Laurie Zawertailo, Peter Selby Concurrent users of tobacco and alcohol are at greater risk of harm than use of either substance alone. It remains unclear how concurrent tobacco and alcohol use affects smoking cessation across levels of alcohol use and related…

https://doi.org/10.1093/ntr/ntae006

Type-switching of short-acting nicotine replacement therapy products and its implications for treatment Created by Scott Veldhuizen, Laurie Zawertailo, Peter Selby The frequency with which people change from one medical treatment to another partly reflects satisfaction with the initial intervention. In this secondary analysis of observational data, we explore switch rates…

https://doi.org/10.1186/s12889-024-18139-z

https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2023.307445?journalCode=ajph

https://doi.org/10.1186/s12875-023-02259-3

Identifying clinical predictors of response to repetitive transcranial magnetic stimulation for smoking cessation: Secondary analysis of a multicenter RCT Victor Tang, Laurie Zawertailo, Peter Selby, Abraham Zangen, Dhvani Mehta, Tony George, Bernard Le Foll, Kristina Gicas. Matthew Sloan, Scott Veldhuizen Tobacco smoking remains a leading cause of morbidity and mortality worldwide. While evidence-based treatments exist for nicotine dependence, many patients do not respond to or cannot tolerate them. Repetitive Transcranial Magnetic Stimulation (rTMS) is a novel, non-invasive neuromodulation treatment that stimulates parts of the brain involved in addiction [1]. Recently, the Brainsway H4 deep TMS coil was cleared by the FDA and Health Canada for the treatment for…

https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1286078